Platelet-activating factor receptor gene polymorphism in Japanese patients with multiple sclerosis

Manabu Osoegawa, Ryuji Miyagishi, Hirofumi Ochi, Itta Nakamura, Masaaki Niino, Seiji Kikuchi, Hiroyuki Murai, Toshiyuki Fukazawa, Motozumi Minohara, Kunio Tashiro, Jun-Ichi Kira

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

We evaluated the association of the platelet-activating factor receptor (PAFR) gene polymorphism (A224D) with the susceptibility and severity of multiple sclerosis (MS) in a Japanese population. DNA was collected from 162 Japanese patients with clinically definite 'conventional' MS (MS) and 245 healthy controls. The missense mutation A224D that impairs PAF-PAFR signaling was determined by polymerase chain reaction restriction fragment length polymorphism. The frequency of the AD/DD genotypes was significantly higher in MS patients (21.0%) than in healthy controls (13.5%) (p=0.045; odds ratio (OR), 1.71; 95% confidence interval (CI), 1.01-2.89). Moreover, the frequency of D allele in MS patients (11.7%) was also significantly higher than those in healthy controls (6.9%) (p=0.019; OR, 1.78; 95% CI, 1.10-2.89). These findings suggest that the PAFR gene missense mutation has a relation to the susceptibility for MS.

Original languageEnglish
Pages (from-to)195-198
Number of pages4
JournalJournal of Neuroimmunology
Volume161
Issue number1-2
DOIs
Publication statusPublished - Jan 1 2005

Fingerprint

Multiple Sclerosis
Genes
Missense Mutation
Odds Ratio
Confidence Intervals
Gene Frequency
Restriction Fragment Length Polymorphisms
platelet activating factor receptor
Genotype
Polymerase Chain Reaction
DNA
Population

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Cite this

Platelet-activating factor receptor gene polymorphism in Japanese patients with multiple sclerosis. / Osoegawa, Manabu; Miyagishi, Ryuji; Ochi, Hirofumi; Nakamura, Itta; Niino, Masaaki; Kikuchi, Seiji; Murai, Hiroyuki; Fukazawa, Toshiyuki; Minohara, Motozumi; Tashiro, Kunio; Kira, Jun-Ichi.

In: Journal of Neuroimmunology, Vol. 161, No. 1-2, 01.01.2005, p. 195-198.

Research output: Contribution to journalArticle

Osoegawa, M, Miyagishi, R, Ochi, H, Nakamura, I, Niino, M, Kikuchi, S, Murai, H, Fukazawa, T, Minohara, M, Tashiro, K & Kira, J-I 2005, 'Platelet-activating factor receptor gene polymorphism in Japanese patients with multiple sclerosis', Journal of Neuroimmunology, vol. 161, no. 1-2, pp. 195-198. https://doi.org/10.1016/j.jneuroim.2004.12.014
Osoegawa, Manabu ; Miyagishi, Ryuji ; Ochi, Hirofumi ; Nakamura, Itta ; Niino, Masaaki ; Kikuchi, Seiji ; Murai, Hiroyuki ; Fukazawa, Toshiyuki ; Minohara, Motozumi ; Tashiro, Kunio ; Kira, Jun-Ichi. / Platelet-activating factor receptor gene polymorphism in Japanese patients with multiple sclerosis. In: Journal of Neuroimmunology. 2005 ; Vol. 161, No. 1-2. pp. 195-198.
@article{a9296b7ff05f404eba6087c9a955baef,
title = "Platelet-activating factor receptor gene polymorphism in Japanese patients with multiple sclerosis",
abstract = "We evaluated the association of the platelet-activating factor receptor (PAFR) gene polymorphism (A224D) with the susceptibility and severity of multiple sclerosis (MS) in a Japanese population. DNA was collected from 162 Japanese patients with clinically definite 'conventional' MS (MS) and 245 healthy controls. The missense mutation A224D that impairs PAF-PAFR signaling was determined by polymerase chain reaction restriction fragment length polymorphism. The frequency of the AD/DD genotypes was significantly higher in MS patients (21.0{\%}) than in healthy controls (13.5{\%}) (p=0.045; odds ratio (OR), 1.71; 95{\%} confidence interval (CI), 1.01-2.89). Moreover, the frequency of D allele in MS patients (11.7{\%}) was also significantly higher than those in healthy controls (6.9{\%}) (p=0.019; OR, 1.78; 95{\%} CI, 1.10-2.89). These findings suggest that the PAFR gene missense mutation has a relation to the susceptibility for MS.",
author = "Manabu Osoegawa and Ryuji Miyagishi and Hirofumi Ochi and Itta Nakamura and Masaaki Niino and Seiji Kikuchi and Hiroyuki Murai and Toshiyuki Fukazawa and Motozumi Minohara and Kunio Tashiro and Jun-Ichi Kira",
year = "2005",
month = "1",
day = "1",
doi = "10.1016/j.jneuroim.2004.12.014",
language = "English",
volume = "161",
pages = "195--198",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Platelet-activating factor receptor gene polymorphism in Japanese patients with multiple sclerosis

AU - Osoegawa, Manabu

AU - Miyagishi, Ryuji

AU - Ochi, Hirofumi

AU - Nakamura, Itta

AU - Niino, Masaaki

AU - Kikuchi, Seiji

AU - Murai, Hiroyuki

AU - Fukazawa, Toshiyuki

AU - Minohara, Motozumi

AU - Tashiro, Kunio

AU - Kira, Jun-Ichi

PY - 2005/1/1

Y1 - 2005/1/1

N2 - We evaluated the association of the platelet-activating factor receptor (PAFR) gene polymorphism (A224D) with the susceptibility and severity of multiple sclerosis (MS) in a Japanese population. DNA was collected from 162 Japanese patients with clinically definite 'conventional' MS (MS) and 245 healthy controls. The missense mutation A224D that impairs PAF-PAFR signaling was determined by polymerase chain reaction restriction fragment length polymorphism. The frequency of the AD/DD genotypes was significantly higher in MS patients (21.0%) than in healthy controls (13.5%) (p=0.045; odds ratio (OR), 1.71; 95% confidence interval (CI), 1.01-2.89). Moreover, the frequency of D allele in MS patients (11.7%) was also significantly higher than those in healthy controls (6.9%) (p=0.019; OR, 1.78; 95% CI, 1.10-2.89). These findings suggest that the PAFR gene missense mutation has a relation to the susceptibility for MS.

AB - We evaluated the association of the platelet-activating factor receptor (PAFR) gene polymorphism (A224D) with the susceptibility and severity of multiple sclerosis (MS) in a Japanese population. DNA was collected from 162 Japanese patients with clinically definite 'conventional' MS (MS) and 245 healthy controls. The missense mutation A224D that impairs PAF-PAFR signaling was determined by polymerase chain reaction restriction fragment length polymorphism. The frequency of the AD/DD genotypes was significantly higher in MS patients (21.0%) than in healthy controls (13.5%) (p=0.045; odds ratio (OR), 1.71; 95% confidence interval (CI), 1.01-2.89). Moreover, the frequency of D allele in MS patients (11.7%) was also significantly higher than those in healthy controls (6.9%) (p=0.019; OR, 1.78; 95% CI, 1.10-2.89). These findings suggest that the PAFR gene missense mutation has a relation to the susceptibility for MS.

UR - http://www.scopus.com/inward/record.url?scp=20044388138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044388138&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2004.12.014

DO - 10.1016/j.jneuroim.2004.12.014

M3 - Article

C2 - 15748960

AN - SCOPUS:20044388138

VL - 161

SP - 195

EP - 198

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -